相关实验视频

Updated: Jul 16, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

免疫相关的8基因组与初级乳腺癌患者新辅助化疗的病理反应的相关性

Ling-Ming Tseng¹, Chi-Cheng Huang², Yi-Fang Tsai³

¹Comprehensive Breast Health Center, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan; Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Experimental Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.

Translational oncology

|September 15, 2023

概括

八个与免疫相关的基因预测了乳腺癌患者的良好预后和化疗反应. 这一发现为个性化治疗策略和改善无复发生存结果提供了新的见解.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

乳腺癌新辅助化疗 (NACT) 的病理完整反应 (pCR) 与预后改善相关.
瘤透淋巴细胞和瘤免疫微环境都与化疗反应有关.
识别NACT反应的预测生物标志物对于优化乳腺癌治疗至关重要.

研究的目的:

在原发性乳腺癌中识别与NACT诱导的PCR相关的免疫相关基因.
评估已识别的免疫相关基因的预后价值.
探索基因表达,免疫细胞透和药物反应之间的相关性.

主要方法:

来自37名接受NACT的乳腺癌患者的新鲜瘤组织的分析.
下一代测序以描述与免疫相关的基因表达.
实现pCR的患者与没有实现pCR的患者之间的基因表达的比较.

主要成果:

12名患者 (32.4%) 获得了pCR,主要是HER2阳性和三阴性乳腺癌亚型.
在pCR患者中观察到八个基因 (KLRK1,IGJ,CD69,CD40LG,MS4A1,CD1C,KLRB1,CA4) 的更高表达.
这8个基因签名与良好的预后,增强的无复发存活率以及与免疫细胞透的积极相关性有关.

结论:

一个8基因免疫特征被确定为预测NACT反应和乳腺癌预后的潜在生物标志物.
这些基因与有利的结果和提高药物敏感性有关.
这种签名可能为指导乳腺癌治疗决策提供有价值的预后见解.

关键词:

乳腺癌乳腺癌乳腺癌新辅助化学疗法新辅助化学疗法病理学的完整反应.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...